Insider trades

William H. Milmoe, Director of Integrated Biopharma INBP, has filed 0 purchases and 66 sales on the open market. Over the past 12 months that comes to a net sale of $2.5M. The latest trade was on 06/24.

William H. Milmoe

Director
First filing
23/03/15
Trades
351 trades
Buys / sales
0 / 66
12-month net buying
−$2.5M
Last trade
06/24

Trading activity

Transactions

Trade type
Open-market sale25/10/1025/10/1540,000 sh$62.50$2,500,000−15.3%
Open-market sale25/07/3125/08/04100,000 sh$47.50$4,750,000−0.6%
CELH
Open-market sale25/07/28–25/07/2925/07/30200,000 sh2 trades$47.50avg.$9,500,000−1.1%
CELH
Open-market sale25/07/0125/07/03300,000 sh3 trades$47.27avg.$14,180,000−1.6%
Open-market sale24/12/1224/12/1665,000 sh$31.15$2,024,750−19.9%
Open-market sale24/05/1724/05/2040,000 sh$92.95$3,718,000−15.0%
CELH
Open-market sale24/05/0724/05/07428,574 sh2 trades$59.67avg.$25,573,010.58−1.8%
CELH
Open-market sale24/05/02–24/05/0624/05/061,285,722 sh6 trades$59.67avg.$76,719,031.74−5.1%
CELH
Open-market sale24/04/29–24/05/0124/05/011,285,704 sh6 trades$59.67avg.$76,717,957.68−4.9%
Open-market sale24/03/0424/03/054,000,000 sh$67.46$269,840,000−13.2%
Open-market sale24/02/2924/03/0444,000 sh$77.00$3,388,000−17.9%
CELH
Open-market saleAmendment24/01/24–24/01/3124/02/08768,877 sh12 trades$43.59avg.$33,511,812.03−2.5%
CELH
Open-market saleAmendment24/01/19–24/01/2324/02/07318,451 sh5 trades$43.40avg.$13,820,016.82−1.0%
CELH
Open-market sale24/02/01–24/02/0224/02/05194,865 sh3 trades$45.38avg.$8,843,634.3−0.6%
CELH
Open-market sale24/01/29–24/01/3124/01/31384,280 sh6 trades$43.47avg.$16,704,136.17−1.2%
CELH
Open-market sale24/01/24–24/01/2624/01/26384,594 sh6 trades$43.70avg.$16,807,575.87−1.2%
CELH
Open-market sale24/01/19–24/01/2324/01/23318,451 sh5 trades$43.40avg.$13,820,016.82−1.0%
Open-market sale23/08/1123/08/1510,000 sh$174.50$1,745,000−33.4%
Open-market sale23/05/1023/05/1220,000 sh$122.03$2,440,600−40.1%
Open-market saleAmendment22/08/0123/02/1410,500 sh$99.94$1,049,370−11.8%